The coronavirus has disrupted manufacturing in China and delivered a shock to global supply chains. One industry that is affected is pharmaceuticals.
China is a major production centre for active pharmaceutical ingredients or APIs.
Globally this has triggered concern. In India, pharma industry leaders have expressed concern that if disruption continues, pharma supply and prices would be affected. Market prices for anti-inflammatory drugs and antibiotics in India have risen sharply as a result of the crisis.
Will the coronavirus disrupt the global supply of pharmaceuticals?
For media enquiries, please contact:
Manager, Group Marketing Communications
Spire Research and Consulting
Phone: (65) 6838 5355
Spire Research and Consulting is the leading research consultancy in global emerging markets. Spire's competitive advantage lies in its ability to deliver actionable intelligence on the external business environment in support of its clients’ strategic decision-making in marketing and business development. Spire's clients include 50 Global Fortune 1000 companies and government agencies in 15 countries. For more information, please visit www.spireresearch.com.